A. Shah and P. Maccarthy, Paracrine and autocrine effects of nitric oxide on myocardial function, Pharmacology & Therapeutics, vol.86, issue.1, pp.49-86, 2000.
DOI : 10.1016/S0163-7258(99)00072-8

M. Semigran, Type 5 Phosphodiesterase Inhibition: The Focus Shifts to the Heart, Circulation, vol.112, issue.17, pp.2589-2591, 2005.
DOI : 10.1161/CIRCULATIONAHA.105.577627

A. Rosenkranz, R. Woods, G. Dusting, and R. Ritchie, Antihypertrophic actions of the natriuretic peptides in adult rat cardiomyocytes: importance of cyclic GMP, Cardiovascular Research, vol.57, issue.2, pp.515-522, 2003.
DOI : 10.1016/S0008-6363(02)00667-3

T. Kempf and K. Wollert, Nitric oxide and the enigma of cardiac hypertrophy, BioEssays, vol.41, issue.6, pp.608-615, 2004.
DOI : 10.1002/bies.20049

E. Takimoto, H. Champion, M. Li, D. Belardi, S. Ren et al., Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy, Nature Medicine, vol.88, issue.2, pp.214-222, 2005.
DOI : 10.1080/004982599238687

D. Souza, S. Davis, M. Baxter, and G. , Autocrine and paracrine actions of natriuretic peptides in the heart, Pharmacology & Therapeutics, vol.101, issue.2, pp.113-129, 2004.
DOI : 10.1016/j.pharmthera.2003.11.001

M. Kuhn, Structure, Regulation, and Function of Mammalian Membrane Guanylyl Cyclase Receptors, With a Focus on Guanylyl Cyclase-A, Circulation Research, vol.93, issue.8, pp.700-709, 2003.
DOI : 10.1161/01.RES.0000094745.28948.4D

P. Padayatti, P. Pattanaik, X. Ma, and F. Van-den-akker, Structural insights into the regulation and the activation mechanism of mammalian guanylyl cyclases, Pharmacology & Therapeutics, vol.104, issue.2, pp.83-99, 2004.
DOI : 10.1016/j.pharmthera.2004.08.003

A. Pyriochou and A. Papapetropoulos, Soluble guanylyl cyclase: more secrets revealed, Cellular Signalling, vol.17, issue.4, pp.407-431718, 2001.
DOI : 10.1016/j.cellsig.2004.09.008

B. Borlaug, V. Melenovsky, T. Marhin, P. Fitzgerald, and D. Kass, Sildenafil Inhibits ??-Adrenergic-Stimulated Cardiac Contractility in Humans, Circulation, vol.112, issue.17, pp.2642-2649, 2005.
DOI : 10.1161/CIRCULATIONAHA.105.540500

M. Ziolo, S. Lewandowski, J. Smith, F. Romano, and G. Wahler, Inhibition of cyclic GMP hydrolysis with zaprinast reduces basal and cyclic AMP-elevated L-type calcium current in guinea-pig ventricular myocytes, British Journal of Pharmacology, vol.104, issue.5, pp.986-994, 2003.
DOI : 10.1038/sj.bjp.0705112

P. Méry, S. Lohmann, U. Walter, and R. Fischmeister, Ca2+ current is regulated by cyclic GMP-dependent protein kinase in mammalian cardiac myocytes., Proceedings of the National Academy of Sciences, vol.88, issue.4, pp.1197-1201, 1991.
DOI : 10.1073/pnas.88.4.1197

J. Kostis, G. Jackson, R. Rosen, E. Barrett-connor, K. Billups et al., Sexual Dysfunction and Cardiac Risk (the Second Princeton Consensus Conference), Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference, pp.313-321, 2005.
DOI : 10.1016/j.amjcard.2005.03.065

I. Verde, G. Vandecasteele, F. Lezoualc-'h, and R. Fischmeister, current in rat ventricular myocytes, British Journal of Pharmacology, vol.484, issue.Suppl. 2, pp.65-74, 1999.
DOI : 10.1038/sj.bjp.0702506

F. Rochais, G. Vandecasteele, F. Lefebvre, C. Lugnier, H. Lum et al., Negative Feedback Exerted by cAMP-dependent Protein Kinase and cAMP Phosphodiesterase on Subsarcolemmal cAMP Signals in Intact Cardiac Myocytes, Journal of Biological Chemistry, vol.279, issue.50, pp.52095-52105, 2004.
DOI : 10.1074/jbc.M405697200